These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7648005)

  • 1. Sex hormones, lipoproteins, and vascular reactivity.
    Sacks FM; Gerhard M; Walsh BW
    Curr Opin Lipidol; 1995 Jun; 6(3):161-6. PubMed ID: 7648005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effects of androgens and other sex hormones on serum lipoproteins].
    Reiner Z
    Lijec Vjesn; 1996 Mar; 118 Suppl 1():33-7. PubMed ID: 8759406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in lipoproteins with various sex steroids.
    Teran AZ; Greenblatt RB; Chaddha JS
    Obstet Gynecol Clin North Am; 1987 Mar; 14(1):107-19. PubMed ID: 3306515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogens, progestins, and coronary artery reactivity in atherosclerotic monkeys.
    Williams JK; Delansorne R; Paris J
    J Steroid Biochem Mol Biol; 1998 Apr; 65(1-6):219-24. PubMed ID: 9699876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women.
    Tilly-Kiesi M; Kahri J; Pyörälä T; Puolakka J; Luotola H; Lappi M; Lahdenperä S; Taskinen MR
    Atherosclerosis; 1997 Mar; 129(2):249-59. PubMed ID: 9105568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
    Bayrak A; Aldemir DA; Bayrak T; Corakçi A; Dursun P
    Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of medroxyprogesterone acetate on endothelium-dependent vasodilation in postmenopausal women receiving estrogen.
    Wakatsuki A; Okatani Y; Ikenoue N; Fukaya T
    Circulation; 2001 Oct; 104(15):1773-8. PubMed ID: 11591613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
    Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender, sex hormones, and vascular tone.
    Orshal JM; Khalil RA
    Am J Physiol Regul Integr Comp Physiol; 2004 Feb; 286(2):R233-49. PubMed ID: 14707008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sex hormones and metabolism of lipoproteins].
    De Gennes JL; Dairou F; Gardette J; Truffert J
    Ann Endocrinol (Paris); 1983; 44(1):59-65. PubMed ID: 6347027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of estrogen and medroxyprogesterone acetate on subpopulations of triglyceride-rich lipoproteins and high-density lipoproteins.
    Lamon-Fava S; Posfai B; Asztalos BF; Horvath KV; Dallal GE; Schaefer EJ
    Metabolism; 2003 Oct; 52(10):1330-6. PubMed ID: 14564686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000.
    Godsland IF
    Fertil Steril; 2001 May; 75(5):898-915. PubMed ID: 11334901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal agents used in lowering lipoprotein(a).
    Soma MR; Meschia M; Bruschi F; Morrisett JD; Paoletti R; Fumagalli R; Crosignani P
    Chem Phys Lipids; 1994 Jan; 67-68():345-50. PubMed ID: 8187233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arthur C. Corcoran Memorial Lecture. Hormones and vasoprotection.
    Oparil S
    Hypertension; 1999 Jan; 33(1 Pt 2):170-6. PubMed ID: 9931100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender differences in the cardiovascular effect of sex hormones.
    Vitale C; Mendelsohn ME; Rosano GM
    Nat Rev Cardiol; 2009 Aug; 6(8):532-42. PubMed ID: 19564884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that parenteral testosterone therapy may improve endothelium-dependent and -independent vasodilation in postmenopausal women already receiving estrogen.
    Worboys S; Kotsopoulos D; Teede H; McGrath B; Davis SR
    J Clin Endocrinol Metab; 2001 Jan; 86(1):158-61. PubMed ID: 11231994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of estrogen replacement therapy on peripheral vasomotor function in postmenopausal women.
    Gilligan DM; Badar DM; Panza JA; Quyyumi AA; Cannon RO
    Am J Cardiol; 1995 Feb; 75(4):264-8. PubMed ID: 7832136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interrelationships among lipoprotein levels, sex hormones, anthropometric parameters, and age in hypogonadal men treated for 1 year with a permeation-enhanced testosterone transdermal system.
    Dobs AS; Bachorik PS; Arver S; Meikle AW; Sanders SW; Caramelli KE; Mazer NA
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1026-33. PubMed ID: 11238481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement therapy lowers plasma Lp(a) concentrations. Comparison of cyclic transdermal and continuous estrogen-progestin regimens.
    Taskinen MR; Puolakka J; Pyörälä T; Luotola H; Bjäörn M; Kääriänen J; Lahdenperä S; Ehnholm C
    Arterioscler Thromb Vasc Biol; 1996 Oct; 16(10):1215-21. PubMed ID: 8857916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sex hormones, glycolipid metabolism, and atherogenesis].
    Sarubbi B; Ducceschi V; Russo B; Di Micco G; Iacono A
    Minerva Med; 1995 Jun; 86(6):265-73. PubMed ID: 7566560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.